About Steven Gillis
Steven Gillis is a director at Pheast Therapeutics.
Steven Gillis first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Steven Gillis in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Steven Gillis works with at each company, as listed on that company's latest Form D.
Pheast Therapeutics, Inc. · Form D, Oct 16, 2025
IW
Irving Weissman
Director
RM
Roy Maute
CEO and director
RR
Raphael Rousseau
Executive officer
JV
Jacob Vogelstein
Director
AB
Amira Barkal
Director
TM
Thomas Marty
Executive officer